FDA recommends “modernizing” review of devices in wake of global investigation

@article{Lenzer2018FDAR,
  title={FDA recommends “modernizing” review of devices in wake of global investigation},
  author={Jeanne Lenzer},
  journal={British Medical Journal},
  year={2018},
  volume={363}
}
  • J. Lenzer
  • Published 27 November 2018
  • Political Science, Medicine
  • British Medical Journal
The US Food and Drug Administration is making changes to how medical devices are cleared for sale after a scathing investigation into the industry. The global investigation into the medical device industry by journalists from 36 countries, including The BMJ , BBC Panorama , and the Guardian and led by the International Consortium of Investigative Journalists, unearthed thousands of documents to reveal rising numbers of malfunctions and injuries.1 Scott Gottlieb, FDA commissioner, and Jeff… Expand
1 Citations
Dermatologic Device Clearance Within the Food and Drug Administration's 510(k) Pathway
TLDR
This study characterize dermatologic device clearance via the 510(k) pathway, which has been criticized for having less stringent clinical data requirements and implications are incompletely described. Expand

References

SHOWING 1-4 OF 4 REFERENCES
Surgeons call for compulsory registers of all new medical devices
  • R. Coombes
  • Medicine, Political Science
  • British Medical Journal
  • 2018
The government must act urgently to reform the lax regulation system governing medical devices, including a compulsory registry of all new implants, says the Royal College of Surgeons. The callExpand
Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices.
TLDR
Premarket approval of cardiovascular devices by the FDA is often based on studies that lack adequate strength and may be prone to bias, according to this systematic review. Expand
The regulatory ancestral network of surgical meshes
TLDR
Surgical meshes are connected through a tangled web of equivalence claims and many meshes recently cleared by the FDA have connections through chains of equivalency to devices which have been recalled from the market due to concerns over clinical safety, raising concerns over the efficacy of the 510(k) route. Expand